View Agent
| Agent Info | |
| Agent: | rociletinib |
| Synonyms: | CO-1686 |
| Drug Status For Certain Diseases: | non-small-cell lung cancer(phase III) |
| Classification: | 3rd-generation, mutant-selective, irreversible EGFR inhibitors |
| Target: | epidermal growth factor receptor |
| KEGG Pathway: | NA |
| Wiki Pathway: | Hair Follicle Development Signaling by ERBB4 Nanoparticle-mediated activation of receptor signaling miR-targeted genes in muscle cell - TarBase EGF/EGFR Signaling Pathway TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer PIP3 activates AKT signaling Aryl Hydrocarbon Receptor AGE/RAGE pathway Arylhydrocarbon receptor (AhR) signaling pathway Bladder Cancer Aryl Hydrocarbon Receptor Pathway Signaling by ERBB2 Integrated Breast Cancer Pathway L1CAM interactions Regulation of Actin Cytoskeleton MAPK Signaling Pathway Extracellular vesicle-mediated signaling in recipient cells Signaling Pathways in Glioblastoma Focal Adhesion Hair Follicle Development miR-targeted genes in lymphocytes - TarBase Signaling by EGFR Gastrin-CREB signalling pathway via PKC and MAPK Spinal Cord Injury Integrated Pancreatic Cancer Pathway ErbB Signaling Pathway Gastric cancer network 2 miR-targeted genes in epithelium - TarBase |